減速することまずない中国M&Aの活動は経済米国から免疫があるようである。 後退
中国報告によって
中国の経済が米国に抗することを彼が感じたとシンガポールのアジアビジネスフォーラムの年次中国M&Aの会議で話すDezan ShiraのクリスDevonshire-Ellis、シニアパートナー及び仲間は今日言った。 後退およびそのM&Aの(合併および獲得)活動は中華人民共和国で続く。
彼の、顕著な学者のグループに作られてコメントし、Deloitte ToucheおよびKPMGの事業金融の頭部を含む弁護士は、それを間、米国示す。 輸入高は米国の繁華街に信号を送る過去の4か月の10%に低下した。 経済、中国語は同じ期間の21%に上がった輸出する、証明する、彼は中国にそれをあらゆる米国から免疫がある保つ支持できる輸出市場が他の所であったこと、言った。 後退。 彼はまた中国の小売り小売販売が最近の中国の新年の間に2007上の16%増加したこと、そしてFDIがUS$11十億余分に1月109%前年増加したことに注意した。 中国の大きい成長を冷却する最近の試みはゆっくり働くようで手形のUS$12十億の最近の注入は多くを使い田園経済を始める蹴りによって国内出費および助けドライブインフレーションを支え商品のための国内および輸入の要求に燃料を供給する。
Concerning M&A, Devonshire-Ellis commented that of China’s US$80 billion plus of deals, much of this was essentially government driven and funded, with little being from the private sector. “It’s interesting to note the two biggest M&A deals last year were by Beijing Enterprise Holdings of Hong Kong, being the listed investment arm of the Beijing government, who purchased Beijing Gas for US$1.5 billion, and China Aluminum, who bought 49 percent of Yunnan Copper for US$1 billion. These are essentially government backed deals. By comparison, much of India’s M&A activity last year involved the private sector,” he said.
Devonshire-Ellis also mentioned that there was some cooling towards China investments at the present, but passed this off on sub-prime lending emotions in the United States rather than China-based intangibles. Noting the MSCI Zhong Hua index has dropped 30 percent since August, and that the value of portfolios such as specialist China investors such as Jupiter China Fund had also decreased by 25 percent during the same period, the facts point to China immunity via its strong export-driven economy not being affected by the slow down in U.S. imports as significant, and that the MSCI will recover ground.
He also pointed out that China was investing heavily in its own infrastructure, with USD67 billion being earmarked for Central Chinese development this year alone, and other huge investments being made in the energy, power supply, waste and water treatment / management and that this expenditure would continue to push M&A activity in China. “It’s driven essentially by a realignment of strategic businesses that are currently poorly integrated,” he said.
However, he passed a word of warning about a Chinese “glass ceiling” when mentioning that Chinese business managers were not in the same global league as those from other emerging markets, such as India. Noting that the Shanghai bourse was still largely taken up by companies all or partly owned by the government, he questioned the credibility of the regulatory system in China and advised that this led Chinese managers into poor standards of corporate governance and accountability. They were playing in China to rules set in China and were not being educated to global standards he mentioned. This, coupled with serious communication difficulties, would mean that no major expansion overseas of Chinese companies, except those strategically positioned by the government for the basic acquisition of raw materials and energy for use in China, would emerge.
China Briefing, the Practical Application of China Business




































March 4th, 2008 at 3:30 pm
Sage advice indeed. A well positioned man to comment on such issues, thanks